Rapid Response to Penpulimab Combined With Anlotinib and Chemotherapy in a Thoracic SMARCA4‐UT Without PD‐L1 Expression: A Case Report and Review of Literature

Rapid Response to Penpulimab Combined With Anlotinib and Chemotherapy in a Thoracic SMARCA4‐UT Without PD‐L1 Expression: A Case Report and Review of Literature

ABSTRACT SMARCA4‐deficient undifferentiated tumor (SMARCA4‐UT) in the chest is a high‐grade malignant tumor that grows rapidly and often carries a poor prognosis. Unfortunately, there are currently no effective treatment available until now. Here, we report a case of SMARCA4‐UT in a patient who show...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuanhang Wang, Kelei Zhao, Jingjing Zhang, Xiaohan Yuan, Yanting Liu, Jinghang Zhang, Ping Lu, Min Zhang
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:The Clinical Respiratory Journal
Subjects:
anlotinib
immune checkpoint inhibitors
thoracic SMARCA4‐deficient undifferentiated tumor
Online Access:https://doi.org/10.1111/crj.70036
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items